VANIQA Side Effects

6874490-9 | Product Name Confusion
on Jul 23, 2010 Female patient from UNITED STATES , 40 years of age, was treated with Vaniqa (View Usage). Patient experienced the following unwanted or unexpected effects: product name confusion. Vaniqa dosage: . During the same period patient was treated with VANICREAM (View Vanicream Review and Vanicream Label ).

6536991-2 | Breast Cancer Female
Patient was taking Vaniqa (View Usage). Patient had the following side effects: breast cancer female on Nov 30, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 190.0 lb, was diagnosed with hair growth abnormal and. Vaniqa dosage: (13.9 % Bid Topical). During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ).

6499772-4 | Breast Cancer Female
Adverse event was reported on Nov 30, 2009 by a Female patient taking Vaniqa (View Usage) (Dosage: (13.9 % Bid Topical)) was diagnosed with hair growth abnormal and. Location: UNITED STATES , 69 years of age, After Vaniqa was administered, patient had the following side effects: breast cancer female.

6338477-7 | Acne Cystic
on Aug 18, 2009 Female patient from SPAIN , 48 years of age, weighting 112.4 lb, was diagnosed with hirsutism and was treated with Vaniqa (View Usage). Patient experienced the following unwanted or unexpected effects: acne cystic. Vaniqa dosage: (1 Df Bid Topical).


6262000-9 | Application Site Discolouration, Application Site Irritation, Application Site Pruritus
on Jul 07, 2009 Female patient from UNITED STATES , 50 years of age, weighting 175.0 lb, was diagnosed with depilation and was treated with Vaniqa (View Usage). Patient had the following side effects: application site discolouration, application site irritation, application site pruritus. Vaniqa dosage: Apply To Affected Area Daily.

6035320-0 | Caesarean Section, Induced Labour, Meconium Stain
Patient was taking Vaniqa (View Usage). After Vaniqa was administered, patient had the following side effects: caesarean section, induced labour, meconium stain on Dec 29, 2008 from IRELAND Additional patient health information: Female patient , 25 years of age, was diagnosed with hair growth abnormal and. Vaniqa dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6035318-2 | Caesarean Section, Foetal Distress Syndrome, Foetal Heart Rate Increased, Meconium Stain
Adverse event was reported on Dec 29, 2008 by a Female patient taking Vaniqa (View Usage) (Dosage: (df)) . Location: IRELAND , weighting 7.00 lb, Patient experienced the following unwanted or unexpected effects: caesarean section, foetal distress syndrome, foetal heart rate increased, meconium stain. Patient was hospitalized.

5989364-5 | Amniocentesis Abnormal, Caesarean Section, Pregnancy
on Nov 18, 2008 Female patient from IRELAND , 25 years of age, was diagnosed with hair growth abnormal and was treated with Vaniqa (View Usage). Patient had the following side effects: amniocentesis abnormal, caesarean section, pregnancy (What is pregnancy?). Vaniqa dosage: (/ Topical). Patient was hospitalized.

5989300-1 | Caesarean Section, Foetal Heart Rate Increased, Meconium Stain
on Nov 18, 2008 Female patient from ITALY , weighting 7.00 lb, was treated with Vaniqa (View Usage). After Vaniqa was administered, patient had the following side effects: caesarean section, foetal heart rate increased, meconium stain. Vaniqa dosage: (df). Patient was hospitalized.

4941243-8 | Condition Aggravated, Hypertrichosis
Patient was taking Vaniqa (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, hypertrichosis on Mar 10, 2006 from UNITED STATES Additional patient health information: Female patient , 46 years of age, weighting 200.0 lb, was diagnosed with hypertrichosis and. Vaniqa dosage: .5g Bid Transdermal.

4897227-1 | Erythema, Heart Rate Increased, Influenza Like Illness, Meningitis, Rash Erythematous, Respiratory Tract Infection
Adverse event was reported on Jan 11, 2006 by a Female patient taking Vaniqa (View Usage) (Dosage: Df Tid Tp) . Location: IRELAND , 19 years of age, weighting 132.9 lb, Patient had the following side effects: erythema, heart rate increased, influenza like illness, meningitis (What is meningitis?), rash erythematous, respiratory tract infection. During the same period patient was treated with DIANETTE (View Dianette Review and Dianette Label ). Patient was hospitalized.

4867945-X | Erythema, Meningitis, Respiratory Tract Infection
on Dec 14, 2005 Female patient from IRELAND , 19 years of age, was treated with Vaniqa (View Usage). After Vaniqa was administered, patient had the following side effects: erythema, meningitis (What is meningitis?), respiratory tract infection. Vaniqa dosage: Df Tid Tp. During the same period patient was treated with DIANETTE (View Dianette Review and Dianette Label ). Patient was hospitalized.

4550313-8 | Premature Ageing, Skin Wrinkling
on Jan 11, 2005 Female patient from , 79 years of age, weighting 135.0 lb, was diagnosed with hirsutism and was treated with Vaniqa (View Usage). Patient experienced the following unwanted or unexpected effects: premature ageing, skin wrinkling. Vaniqa dosage: Applyed Twice Daily.